(Q44577742)

4 December 2017

Adjuvant chemotherapy in early breast cancer and incidence of new primary malignancies (English)

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)91100-9

27 October 2022

author name string

R. Arriagada

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1678800

27 October 2022

L. E. Rutqvist

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1678800

27 October 2022

language of work or name

English

0 references

publication date

1 August 1991

1 reference

4 December 2017

31 August 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1678800

full work available at URL

27 October 2022

https://api.elsevier.com/content/article/PII:0140673691911009?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)91100-9

https://api.elsevier.com/content/article/PII:0140673691911009?httpAccept=text/plain

27 October 2022

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)91100-9

27 October 2022

1 reference

4 December 2017

338

1 reference

4 December 2017

8766

1 reference

4 December 2017

535-538

1 reference

Breast cancer and acute leukemia: Report of 24 cases and review of the literature

4 December 2017

2

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)91100-9

Secondary acute myelocytic leukemia after adjuvant therapy for early-stage breast carcinoma. A new complication of cyclophosphamide, methotrexate, and 5-fluorouracil therapy

27 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)91100-9

Radiotherapy, chemotherapy, and tamoxifen as adjuncts to surgery in early breast cancer: a summary of three randomized trials

27 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)91100-9

The Stockholm trial on adjuvant tamoxifen in early breast cancer. Correlation between estrogen receptor level and treatment effect

27 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)91100-9

Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers

27 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)91100-9

A method of analysis taking into account competing events: application to the study of digestive complications following irradiation for cervical cancer

27 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)91100-9

Improved methodology for analyzing local and distant recurrence

27 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)91100-9

Second malignancies after CMF for resectable breast cancer

27 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)91100-9

Second cancer following chemotherapy and radiotherapy. An epidemiological perspective

27 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)91100-9

Postoperative radiotherapy and late mortality: evidence from the Cancer Research Campaign trial for early breast cancer

27 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)91100-9

Leukemia after radiotherapy for first primary cancers of various anatomic sites

27 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)91100-9

Impact of radiation therapy and/or chemotherapy on the risk for a second malignancy after breast cancer.

27 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)91100-9

Cytotoxic chemotherapy induces cell differentiation in small-cell lung carcinoma

27 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)91100-9

Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck

27 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)91100-9

Coming of age--the chemoprevention of cancer

27 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)91100-9

Rationally designed combination chemotherapy for the treatment of patients with recalcitrant psoriasis

27 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)91100-9

Leukemia in breast cancer patients following adjuvant chemotherapy or postoperative radiation: the NSABP experience

27 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)91100-9

27 October 2022

Identifiers

1 reference

release_lc7irnuhiffdpgk64jccnvjqoq

4 December 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/lc7irnuhiffdpgk64jccnvjqoq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference